FDAnews Device Daily Bulletin

MEDICAL DEVICE CEOS INVEST IN PLUROMED

Nov. 28, 2005
A A

Pluromed, a private medical device company that may revolutionize hemostasis during surgery and interventional procedures, recently announced that 7 CEOs, former CEOs and founders of U.S. medical device companies have invested in the initial close of its current Series A Convertible Preferred Stock Offering. "We believe it is important to have investors that substantiate our view of the business opportunity", says Jean-Marie Vogel, Pluromed co-founder and CEO. "I feel very privileged to have the ability to access that extraordinary pool of talent, and expect it to be a major asset as we continue to seek their advice and guidance to build the value of Pluromed."

PRWeb (http://www.prweb.com/printer.php?prid=313982)